These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 19058028
1. Atherosclerotic plaque imaging by PET/CT; can inactive, active and mixed plaques be discerned? van der Wall EE, Schuijf JD, Jukema JW, Bax JJ, van der Laarse A. Int J Cardiovasc Imaging; 2009 Feb; 25(2):141-4. PubMed ID: 19058028 [No Abstract] [Full Text] [Related]
2. Assessment of inactive, active and mixed atherosclerotic plaques by 18F-FDG-PET; an age group-based correlation with cardiovascular risk factors. Wassélius J, Larsson S, Sundin A, Jacobsson H. Int J Cardiovasc Imaging; 2009 Feb; 25(2):133-40. PubMed ID: 18784986 [Abstract] [Full Text] [Related]
3. FDG-accumulating atherosclerotic plaques identified with 18F-FDG-PET/CT in 141 patients. Wassélius JA, Larsson SA, Jacobsson H. Mol Imaging Biol; 2009 Feb; 11(6):455-9. PubMed ID: 19424759 [Abstract] [Full Text] [Related]
4. Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study. Niccoli Asabella A, Ciccone MM, Cortese F, Scicchitano P, Gesualdo M, Zito A, Di Palo A, Angiletta D, Regina G, Marzullo A, Rubini G. Ann Nucl Med; 2014 Jul; 28(6):571-9. PubMed ID: 24737136 [Abstract] [Full Text] [Related]
5. FDG PET/CT Imaging of Carotid Atherosclerosis. Ali A, Tawakol A. Neuroimaging Clin N Am; 2016 Feb; 26(1):45-54. PubMed ID: 26610659 [Abstract] [Full Text] [Related]
6. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology. Hyafil F, Cornily JC, Rudd JH, Machac J, Feldman LJ, Fayad ZA. J Nucl Med; 2009 Jun; 50(6):959-65. PubMed ID: 19443582 [Abstract] [Full Text] [Related]
7. Monitoring plaque composition: is it worthwile? van der Laarse A, van der Wall EE. Int J Cardiovasc Imaging; 2009 Mar; 25(3):259-61. PubMed ID: 19037748 [No Abstract] [Full Text] [Related]
9. Time-to-time correlation of high-risk atherosclerotic lesions identified with [(18)F]-FDG-PET/CT. Wassélius J, Larsson S, Jacobsson H. Ann Nucl Med; 2009 Jan; 23(1):59-64. PubMed ID: 19205839 [Abstract] [Full Text] [Related]
10. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT. Hetterich H, Rominger A, Walter L, Habs M, Volpers S, Hacker M, Reiser MF, Bartenstein P, Saam T. Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891 [Abstract] [Full Text] [Related]
11. Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement. Huet P, Burg S, Le Guludec D, Hyafil F, Buvat I. J Nucl Med; 2015 Apr; 56(4):552-9. PubMed ID: 25722452 [Abstract] [Full Text] [Related]
12. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Roh JL, Yeo NK, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY. Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656 [Abstract] [Full Text] [Related]
19. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques. Silvola JM, Saraste A, Laitinen I, Savisto N, Laine VJ, Heinonen SE, Ylä-Herttuala S, Saukko P, Nuutila P, Roivainen A, Knuuti J. JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786 [Abstract] [Full Text] [Related]